Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients / Bichet, Daniel; Boudes, Pol; El Din, Sharaf; Ezgu, Fatih; Feliciani, Claudio; Zampetti, Anna; Lourenco, Charles Marques; Nicholls, Kathy; Castelli, Jeff; Overton, Chemise; Sitaraman, Sheela; Benjamin, Elfrida; Wu, Xiaoyang. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - 105:2(2012), p. S21. [10.1016/j.ymgme.2011.11.029]

Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients

FELICIANI, Claudio;
2012-01-01

2012
Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients / Bichet, Daniel; Boudes, Pol; El Din, Sharaf; Ezgu, Fatih; Feliciani, Claudio; Zampetti, Anna; Lourenco, Charles Marques; Nicholls, Kathy; Castelli, Jeff; Overton, Chemise; Sitaraman, Sheela; Benjamin, Elfrida; Wu, Xiaoyang. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - 105:2(2012), p. S21. [10.1016/j.ymgme.2011.11.029]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2785563
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact